Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus Strains
- 1 February 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (2), 421-423
- https://doi.org/10.1128/aac.43.2.421
Abstract
The activities of eight fluoroquinolones and linezolid, quinupristin-dalfopristin (Synercid), gentamicin, and vancomycin were tested against 96 ciprofloxacin-susceptible and 205 ciprofloxacin-resistant Staphylococcus aureus strains. Overall, clinafloxacin, followed by moxifloxacin and trovafloxacin, was the most active quinolone tested. For all isolates, linezolid and quinupristin-dalfopristin showed activities that were at least comparable to vancomycin, with no cross-resistance to any other test compound.Keywords
This publication has 17 references indexed in Scilit:
- In Vitro Activities of Clinafloxacin against Contemporary Clinical Bacterial Isolates from 10 North American CentersAntimicrobial Agents and Chemotherapy, 1998
- Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 1998
- Typing of methicillin-resistant Staphylococcus aureus isolates from Dusseldorf by six genotypic methodsJournal of Medical Microbiology, 1998
- Epidemiology of Quinolone ResistanceDrugs, 1995
- In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1992
- In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistantStaphylococcus aureus andStaphylococcus epidermidisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- RP 59500: a proposed mechanism for its bactericidal activityJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1992
- Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinoloneAntimicrobial Agents and Chemotherapy, 1991
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988